Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

Share

Novo Nordisk Pharma Operations A/S

Closing information (x1000 NOK)

Closing information 2023/12 2022/12 2021/12
Turnover 163,343 More Arrow 299,302 Less Arrow 132,282
Earnings before taxes 10,203 Less Arrow 6,765 Less Arrow 5,899
Total assets 117,452 More Arrow 192,160 Less Arrow 95,037
Current assets 105,286 Less Arrow 78,812 More Arrow 80,258
Current liabilities 53,406 Less Arrow 49,483 More Arrow 56,991
Equity capital 43,625 More Arrow 101,507 Less Arrow 27,545
- share capital 754 Less Arrow 708 Less Arrow 671
Employees (average) 0 Equal arrow 0 Equal arrow 0

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 37.1% More Arrow 52.8% Less Arrow 29.0%
Turnover per employee
Profit as a percentage of turnover 6.2% Less Arrow 2.3% More Arrow 4.5%
Return on assets (ROA)
Current ratio 197.1% Less Arrow 159.3% Less Arrow 140.8%
Return on equity (ROE) 23.4% Less Arrow 6.7% More Arrow 21.4%
Change turnover -155,555 More Arrow 159,687 Less Arrow 26,063
Change turnover % -49% More Arrow 114% Less Arrow 25%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees %

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.